Alnylam Pharmaceuticals Statistics
Total Valuation
ALNY has a market cap or net worth of $40.95 billion. The enterprise value is $40.58 billion.
| Market Cap | 40.95B |
| Enterprise Value | 40.58B |
Important Dates
The next confirmed earnings date is Thursday, April 30, 2026, before market open.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ALNY has 132.62 million shares outstanding. The number of shares has increased by 5.51% in one year.
| Current Share Class | 132.62M |
| Shares Outstanding | 132.62M |
| Shares Change (YoY) | +5.51% |
| Shares Change (QoQ) | -0.78% |
| Owned by Insiders (%) | 0.38% |
| Owned by Institutions (%) | 99.01% |
| Float | 132.07M |
Valuation Ratios
The trailing PE ratio is 131.13 and the forward PE ratio is 46.24.
| PE Ratio | 131.13 |
| Forward PE | 46.24 |
| PS Ratio | 10.91 |
| Forward PS | 7.13 |
| PB Ratio | 51.25 |
| P/TBV Ratio | 51.35 |
| P/FCF Ratio | 87.07 |
| P/OCF Ratio | 77.32 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 72.83, with an EV/FCF ratio of 87.20.
| EV / Earnings | 129.35 |
| EV / Sales | 10.93 |
| EV / EBITDA | 72.83 |
| EV / EBIT | 80.91 |
| EV / FCF | 87.20 |
Financial Position
The company has a current ratio of 2.76, with a Debt / Equity ratio of 3.76.
| Current Ratio | 2.76 |
| Quick Ratio | 2.51 |
| Debt / Equity | 3.76 |
| Debt / EBITDA | 4.70 |
| Debt / FCF | 6.38 |
| Interest Coverage | 1.99 |
Financial Efficiency
Return on equity (ROE) is 73.28% and return on invested capital (ROIC) is 86.03%.
| Return on Equity (ROE) | 73.28% |
| Return on Assets (ROA) | 6.81% |
| Return on Invested Capital (ROIC) | 86.03% |
| Return on Capital Employed (ROCE) | 14.33% |
| Weighted Average Cost of Capital (WACC) | 6.49% |
| Revenue Per Employee | $1.49M |
| Profits Per Employee | $125,499 |
| Employee Count | 2,500 |
| Asset Turnover | 0.81 |
| Inventory Turnover | 8.46 |
Taxes
In the past 12 months, ALNY has paid $9.41 million in taxes.
| Income Tax | 9.41M |
| Effective Tax Rate | 2.91% |
Stock Price Statistics
The stock price has increased by +22.86% in the last 52 weeks. The beta is 0.38, so ALNY's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | +22.86% |
| 50-Day Moving Average | 321.87 |
| 200-Day Moving Average | 393.18 |
| Relative Strength Index (RSI) | 43.54 |
| Average Volume (20 Days) | 1,002,546 |
Short Selling Information
The latest short interest is 5.06 million, so 3.81% of the outstanding shares have been sold short.
| Short Interest | 5.06M |
| Short Previous Month | 4.37M |
| Short % of Shares Out | 3.81% |
| Short % of Float | 3.83% |
| Short Ratio (days to cover) | 4.49 |
Income Statement
In the last 12 months, ALNY had revenue of $3.71 billion and earned $313.75 million in profits. Earnings per share was $2.33.
| Revenue | 3.71B |
| Gross Profit | 3.03B |
| Operating Income | 501.58M |
| Pretax Income | 323.15M |
| Net Income | 313.75M |
| EBITDA | 557.24M |
| EBIT | 501.58M |
| Earnings Per Share (EPS) | $2.33 |
Balance Sheet
The company has $2.91 billion in cash and $2.97 billion in debt, with a net cash position of -$60.31 million or -$0.45 per share.
| Cash & Cash Equivalents | 2.91B |
| Total Debt | 2.97B |
| Net Cash | -60.31M |
| Net Cash Per Share | -$0.45 |
| Equity (Book Value) | 789.18M |
| Book Value Per Share | 5.96 |
| Working Capital | 2.58B |
Cash Flow
In the last 12 months, operating cash flow was $524.08 million and capital expenditures -$58.70 million, giving a free cash flow of $465.38 million.
| Operating Cash Flow | 524.08M |
| Capital Expenditures | -58.70M |
| Depreciation & Amortization | 55.66M |
| Net Borrowing | -546.95M |
| Free Cash Flow | 465.38M |
| FCF Per Share | $3.51 |
Margins
Gross margin is 81.64%, with operating and profit margins of 13.51% and 8.45%.
| Gross Margin | 81.64% |
| Operating Margin | 13.51% |
| Pretax Margin | 8.70% |
| Profit Margin | 8.45% |
| EBITDA Margin | 15.00% |
| EBIT Margin | 13.51% |
| FCF Margin | 12.53% |
Dividends & Yields
ALNY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.51% |
| Shareholder Yield | -5.51% |
| Earnings Yield | 0.77% |
| FCF Yield | 1.15% |
Analyst Forecast
The average price target for ALNY is $471.00, which is 52.54% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $471.00 |
| Price Target Difference | 52.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 28 |
| Revenue Growth Forecast (5Y) | 17.29% |
| EPS Growth Forecast (5Y) | 41.25% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ALNY has an Altman Z-Score of 6.35 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.35 |
| Piotroski F-Score | 5 |